Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

NYSE:MAGN - New York Stock Exchange, Inc. - US55939A1079 - Common Stock - Currency: USD

13.07  -0.33 (-2.46%)

After market: 13.07 0 (0%)

Fundamental Rating

3

Taking everything into account, MAGN scores 3 out of 10 in our fundamental rating. MAGN was compared to 9 industry peers in the Paper & Forest Products industry. MAGN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MAGN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MAGN had negative earnings in the past year.
In the past year MAGN has reported a negative cash flow from operations.
In multiple years MAGN reported negative net income over the last 5 years.
In multiple years MAGN reported negative operating cash flow during the last 5 years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

MAGN has a Return On Assets (-3.26%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -12.12%, MAGN is doing worse than 66.67% of the companies in the same industry.
With a decent Return On Invested Capital value of 1.08%, MAGN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MAGN is below the industry average of 6.22%.
Industry RankSector Rank
ROA -3.26%
ROE -12.12%
ROIC 1.08%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN has a better Operating Margin (2.16%) than 66.67% of its industry peers.
MAGN's Operating Margin has declined in the last couple of years.
MAGN has a Gross Margin (10.57%) which is in line with its industry peers.
MAGN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.16%
PM (TTM) N/A
GM 10.57%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

MAGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MAGN has less shares outstanding
MAGN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MAGN is higher compared to a year ago.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

MAGN has an Altman-Z score of 0.88. This is a bad value and indicates that MAGN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.88, MAGN is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.82 is on the high side and indicates that MAGN has dependencies on debt financing.
MAGN has a worse Debt to Equity ratio (1.82) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACC0.14
WACC7.47%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.40 indicates that MAGN has no problem at all paying its short term obligations.
The Current ratio of MAGN (2.40) is comparable to the rest of the industry.
A Quick Ratio of 1.54 indicates that MAGN should not have too much problems paying its short term obligations.
MAGN has a Quick ratio (1.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.54
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

MAGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.18%.
Looking at the last year, MAGN shows a decrease in Revenue. The Revenue has decreased by -7.09% in the last year.
Measured over the past years, MAGN shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%

3.2 Future

MAGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.84% yearly.
Based on estimates for the next years, MAGN will show a very strong growth in Revenue. The Revenue will grow by 20.99% on average per year.
EPS Next Y-14%
EPS Next 2Y22.07%
EPS Next 3Y46.71%
EPS Next 5Y39.84%
Revenue Next Year120.68%
Revenue Next 2Y41.29%
Revenue Next 3Y27.88%
Revenue Next 5Y20.99%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Also next year MAGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

MAGN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.15
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 46.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.07%
EPS Next 3Y46.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNERA CORP

NYSE:MAGN (8/15/2025, 8:04:01 PM)

After market: 13.07 0 (0%)

13.07

-0.33 (-2.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)N/A N/A
Inst Owners91.33%
Inst Owner Change3.21%
Ins Owners0.54%
Ins Owner Change31.69%
Market Cap465.29M
Analysts45.71
Price Target14.28 (9.26%)
Short Float %15.54%
Short Ratio6.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB 2.29
EV/EBITDA 11.15
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-1.82
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS61.45
BVpS30.7
TBVpS5.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -12.12%
ROCE 1.37%
ROIC 1.08%
ROICexc 1.17%
ROICexgc 1.63%
OM 2.16%
PM (TTM) N/A
GM 10.57%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.82
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 32.05%
Cap/Sales 2.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.54
Altman-Z 0.88
F-Score5
WACC7.47%
ROIC/WACC0.14
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-14%
EPS Next 2Y22.07%
EPS Next 3Y46.71%
EPS Next 5Y39.84%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%
Revenue Next Year120.68%
Revenue Next 2Y41.29%
Revenue Next 3Y27.88%
Revenue Next 5Y20.99%
EBIT growth 1Y264.61%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y86.31%
EBIT Next 5Y61.31%
FCF growth 1Y-139.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-277.25%
OCF growth 3YN/A
OCF growth 5YN/A